Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
Pier Luigi Luigi ZinzaniGilles Andre SallesAlison J MoskowitzArmando SantoroAmitkumar MehtaPaul M BarrNeha Mehta-ShahGraham P CollinsStephen M AnsellJoshua D BrodyEva Domingo-DomenechNathalie A JohnsonDavid CunninghamSilvia FerrariJulie LisanoJennifer KrajewskiRachael WenAlev AkyolRussell CroweKerry Joane SavagePublished in: Blood advances (2024)